nameKyle Piskel
roleCFO
contactnot published
filings
| 2024-04-09 | leadership change | receipt |
quotes
This growth was largely due to increased personnel costs, primarily due to the expansion of our ClonoSeq field team and related customer operations teams, as well as increased travel and customer event-related expenses.
May 4, 2022 / CFO / receipt, needs a key / Kyle Piskel, CFO | earnings call 2022-05-04 | transcript eeb433a1-8848-441f-b039-ad55b52604cf | chars 15183-15402 | segment 15
steadybase-$